CJC-1295 (No DAC) + IPA

CJC-1295 is a synthetic peptide analog of growth hormone-releasing hormone (GHRH), studied in research settings for its role in stimulating natural growth hormone signaling pathways. In simple terms, it is used in laboratory research to better understand how the body regulates growth hormone release, and how extending that signaling may influence downstream metabolic and cellular …

$45.00

CJC-1295 (No DAC) + Ipamorelin is a research-grade peptide combination studied in laboratory settings for its interaction with growth hormone regulatory pathways. In simple terms, researchers use this pairing to observe how two different signaling mechanisms within the endocrine system can influence natural growth hormone pulse dynamics in controlled biological models.

CJC-1295 (No DAC) is a synthetic analog of growth hormone-releasing hormone (GHRH) that binds to GHRH receptors in the pituitary gland, supporting endogenous growth hormone release through receptor-mediated signaling. Because it does not include the Drug Affinity Complex (DAC), it has a shorter half-life and produces more transient, pulse-like activity in research models.

Ipamorelin is a selective growth hormone secretagogue that acts as a ghrelin receptor (GHSR-1a) agonist. It is commonly studied for its ability to stimulate growth hormone release without significantly affecting other pituitary hormones such as cortisol or prolactin in preclinical research settings. Its selective receptor profile makes it a widely used compound in endocrine signaling studies.

When studied together, CJC-1295 (No DAC) and Ipamorelin provide a dual-pathway model for growth hormone release—activating both GHRH and ghrelin receptor pathways. This combination is often used in research to evaluate synergistic effects on somatotropic axis signaling, pulsatile hormone secretion patterns, and downstream endocrine responses such as IGF-1 modulation in laboratory models.

This product is intended strictly for laboratory research purposes only and is not approved for human consumption, medical use, or diagnostic applications.

Key Research Areas

  • Dual-pathway growth hormone signaling (GHRH + ghrelin receptors)
  • Somatotropic axis regulation studies
  • Pulsatile hormone secretion modeling
  • Pituitary endocrine response research
  • Growth hormone secretagogue mechanism studies

Chemical Information

  • Compound Name: CJC-1295
  • Type: Synthetic GHRH analog peptide
  • Variants: With DAC / Without DAC
  • Mechanism: Growth hormone-releasing hormone receptor agonist
  • Research Focus: Endocrine and metabolic signaling pathways
  • Half-life: Extended in DAC-modified version (albumin binding)

Important Notice

This compound is sold strictly for laboratory research purposes only. It is not intended for human consumption, medical treatment, or diagnostic use. Proper handling and regulatory compliance are required by the purchaser.

Additional information